The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Connective Tissue Disease-associated Interstitial Lung Diseases (CTD-ILD) — Report from OMERACT CTD-ILD Working Group
Open accessAbstract
Objective.: Interstitial lung disease (ILD) is common in connective tissue disease (CTD) and is the leading cause of mortality. Investigators have used certain outcome measures in randomized controlled trials (RCT) in CTD-ILD, but the lack of a systematically developed, CTD-specific index that captures all measures relevant and meaningful to patients with CTD-ILD has left a large and conspicuous gap in CTD-ILD research. Methods.: The CTD-ILD working group, under the aegis of the Outcome Measures in Rheumatology (OMERACT) initiative, has completed a consensus group exercise to reach harmony on core domains and items for inclusion in RCT in CTD-ILD. During the OMERACT 12 meeting, consensus was sought on domains and core items for inclusion in RCT. In addition, consensus was pursued on a definition of response in RCT. Consensus was defined as ≥ 75% agreement among the participants. Results.: OMERACT 12 participants endorsed the domains with minimal modifications. Clinically meaningful progression for CTD-ILD was proposed as ≥ 10% relative decline in forced vital capacity (FVC) or ≥ 5% to < 10% relative decline in FVC and ≥ 15% relative decline in DLCO. Conclusion.: There is consensus on domains for inclusion in RCT in CTD-ILD and on a definition of clinically meaningful progression. Data-driven approaches to validate these results in different cohorts and RCT are needed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Developing core outcome measurement sets for clinical trials: OMERACT filter 2.0
Boers, M., Kirwan, J. R., Wells, G., Beaton, D., Gossec, L., d'Agostino, M.-A., Conaghan, P. G., Bingham, C. O., Brooks, P., Landewé, R., et al. (2014) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2013.11.013 · Cited by 781
Self-citation
Cited by
Goh, N. S., Hoyles, R. K., Denton, C. P., Hansell, D. M., Renzoni, E. A., Maher, T. M., Nicholson, A. G., & Wells, A. U. (2017) · Arthritis & Rheumatology · doi:10.1002/art.40130 · Cited by 354
Self-citationTracking Impact of Interstitial Lung Disease in Systemic Sclerosis in a Complete Nationwide Cohort
Hoffmann-Vold, A.-M., Fretheim, H., Halse, A.-K., Seip, M., Bitter, H., Wallenius, M., Garen, T., Salberg, A., Brunborg, C., Midtvedt, Ø., et al. (2019) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201903-0486oc · Cited by 257
Zou, M., Hu, X., Song, W., Gao, H., Wu, C., Zheng, W., & Cheng, Z. (2023) · Clinical and Experimental Medicine · doi:10.1007/s10238-023-01214-x · Cited by 10
Metadata
- Authors
- Khanna, D., Mittoo, S., Aggarwal, R., Proudman, S. M., Dalbeth, N., Matteson, E. L., Brown, K., Flaherty, K., Wells, A. U., Seibold, J. R., & Strand, V.
- Venue
- The Journal of Rheumatology
- Publisher
- The Journal of Rheumatology
- Published
- 2015-03-01
- Volume
- 42
- Issue
- 11
- Pages
- 2168-2171
- ISSN
- 0315-162X (ISSN-L)
- 1499-2752
- OpenAlex
- W1964646819
- Cited by
- 193
- References
- 1
- FWCI
- 7.14
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Connective Tissue Disease-associated Interstitial Lung Diseases (CTD-ILD) — Report from OMERACT CTD-ILD Working Group. https://app.cochat.ai/papers/10.3899/jrheum.141182
- The paper
- Khanna, D., Mittoo, S., Aggarwal, R., Proudman, S. M., Dalbeth, N., Matteson, E. L., Brown, K., Flaherty, K., Wells, A. U., Seibold, J. R., & Strand, V. (2015). Connective Tissue Disease-associated Interstitial Lung Diseases (CTD-ILD) — Report from OMERACT CTD-ILD Working Group. The Journal of Rheumatology. https://doi.org/10.3899/jrheum.141182
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.